Nonetheless, inhaled antibiotics will continue to be an important mainstay in the CF therapeutic regimen, given that most adult subjects chronically harbor respiratory pathogens and that CFTR correction by modulator therapy is partial. This evidence concerns the gene CFTR and cystic fibrosis.